Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07357428 · ClinicalTrials.gov registry record · NA

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

A NA study of Stroke and Amyotrophic Lateral Sclerosis, sponsored by Paradromics.

Recruiting
Registry status
NA
Development phase
2
Enrollment target
1
Study location

NCT07357428 is a NA study of Stroke and Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Paradromics. The registered enrollment target is 2 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07357428, a NA study of Stroke and Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Paradromics.

RECRUITING
Registry status
NA
Development phase
2 participants
Enrollment target
1
Study location

Study Summary

The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with impaired communication as a result of severe loss of voluntary motor control; and (2) to provide control of computer devices for individuals with severe loss of voluntary motor control of the upper extremity.

Conditions Studied

Stroke Amyotrophic Lateral Sclerosis Cervical Spinal Cord Injury Tetraplegia/Tetraparesis Dysarthria Neuromuscular Disease

Interventions

  • DEVICE Connexus Brain-Computer Interface

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2026-01
Est. Completion 2032-01
Phase NA

Sponsor

Paradromics

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07357428

The ClinicalTrials.gov registry entry for NCT07357428 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Paradromics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Connexus Brain-Computer Interface is the first listed.

NCT07357428 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT07357428 about?

NCT07357428 is a clinical study titled "Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)". The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with i...

What is the current status of trial NCT07357428?

This trial is currently recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2026-01. Estimated completion is 2032-01.

What conditions does trial NCT07357428 study?

This clinical trial studies the following conditions: Stroke, Amyotrophic Lateral Sclerosis, Cervical Spinal Cord Injury, Tetraplegia/Tetraparesis, Dysarthria.

What interventions are being tested in trial NCT07357428?

The interventions under investigation include: Connexus Brain-Computer Interface (DEVICE).

Who is sponsoring clinical trial NCT07357428?

This trial is sponsored by Paradromics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07357428 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Amyotrophic Lateral Sclerosis

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.